Low Sensitivity of Abbreviated Tilt Table Testing for Diagnosing Postural Tachycardia Syndrome in Adults With ME/CFS.
van Campen, C Linda M C, Rowe, Peter C, Visser, Frans C · Frontiers in pediatrics · 2018 · DOI
Quick Summary
Many people with ME/CFS experience dizziness and rapid heartbeat when standing up, a condition called POTS. This study found that when doctors use shortened tilt table tests (lasting only 2 minutes) to diagnose POTS, they miss more than half of the patients who actually have it. The researchers recommend using the full 10-minute test instead of the abbreviated version to properly identify POTS in ME/CFS patients.
Why It Matters
Orthostatic intolerance is a core feature in many ME/CFS case definitions, making accurate POTS diagnosis clinically important. This study demonstrates that abbreviated tilt testing substantially underdiagnoses POTS and could lead to missed cases in both clinical practice and epidemiologic research, affecting prevalence estimates and patient management decisions.
Observed Findings
Of 627 ME/CFS patients evaluated, 155 (25%) met POTS criteria using full 10-minute upright tilt testing.
The median time to reaching POTS heart rate criteria was 3 minutes.
A 2-minute tilt table test would miss 55% of patients with POTS when using 10-minute criteria as the reference standard.
Time to POTS criterion achievement did not significantly differ by patient age, sex, ME/CFS disease duration, or degree of hypocapnia during testing.
Inferred Conclusions
Abbreviated tilt table tests (under 10 minutes) substantially underdiagnose POTS in ME/CFS populations and should not be used for clinical diagnosis or prevalence studies.
The high false-negative rate of brief testing suggests that diagnostic protocols require the full 10-minute upright duration to reliably identify POTS.
POTS diagnostic criteria appear consistently timed across demographic subgroups in ME/CFS, supporting uniform testing protocols.
Remaining Questions
What is the optimal tilt table duration and angle for diagnosing POTS specifically in ME/CFS populations versus other patient groups?
Do patients on orthostatic medications show different time-to-criterion patterns, and how should they be assessed diagnostically?
What This Study Does Not Prove
This study does not prove that POTS causes ME/CFS or vice versa—only that the two conditions frequently co-occur in this population. It does not establish optimal tilt testing protocols across all patient populations or other healthcare settings, and the single-center design limits generalizability to other geographic regions or clinical contexts.